Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Third Rock woos top Roche scientist Sanjay Keswani to the helm of biotech startup Rheos Medicines
7 years ago
Startups
Partnering with Amgen vet Sean Harper, veteran VC Beth Seidenberg unveils a $320M fund and a unique focus on…wait for it…LA
7 years ago
Financing
David Schenkein is passing the reins at Agios to Jackie Fouse after a star-making 10-year run
7 years ago
Once charged with speeding up Eli Lilly’s slow-mo R&D group, Anne White is handed the reins at Lilly Oncology
7 years ago
Coming to America: Rehan Verjee jumps up to top US healthcare post for Merck KGaA in high-level revamp
7 years ago
Amgen vet Laura Hamill takes commercial reins at Gilead amid executive shakeup
7 years ago
Bristol-Myers promotes a commercial player to top sales job — replacing new Amgen exec Murdo Gordon
7 years ago
Vivek Ramaswamy bags $100M in risk capital to back his latest PhIII gamble at Dermavant — while Urovant dives into gene therapy
7 years ago
Financing
Sangamo researcher charged with insider trading in latest round of SEC accusations leveled at a biotech exec
7 years ago
Pharma
As Shkreli attorney Greebel heads to his own prison cell, the bad boy of biotech is still skewering enemies in new blog
7 years ago
'Gap years' are for adults, too: Ex-Foundation exec Steve Kafka joins Third Rock after globetrotting break
7 years ago
One more gig: Steven Paul decides to extend a 35-year track record with one last shot at a big development program
7 years ago
Startups
An exodus of top Gilead execs continues as newly named CMO Andrew Cheng heads for the exit
7 years ago
Ex-Pfizer exec Geno Germano joins nanoparticle startup Elucida Oncology as CEO
7 years ago
Rogerio Vivaldi jumps from Bioverativ buyout to leading Flagship-seeded Sigilon's Holy Grail pursuit
7 years ago
CEO interrupted: Novartis chief Narasimhan looks to new ethics czar to clean up after the lingering Cohen mess
7 years ago
Pharma
Pfizer Oncology loses its CMO to Allergan as cancer exec Charles Hugh-Jones makes a career leap
7 years ago
Insider trading in Washington: NY Congressman indicted for sharing inside biotech tips ahead of massive trial failure
7 years ago
GSK chief Emma Walmsley rounds out her top team with CFO pick — but performance lags
7 years ago
Bioregnum
Opinion
Tom Hughes jumps ship at Zafgen and gets back to the helm of a noteworthy biotech
7 years ago
Novartis oncology vet Stefan Scherer joins biotech migration to head clinical work, CAR-T partnership at Cellectis
7 years ago
Genentech I/O chief Dan Chen heads to an upstart biotech looking to create a landmark advance on antibodies
7 years ago
Startups
Big Pharma analyst Tim Anderson drops off the radar at Bernstein, headed to a new research home
7 years ago
Amgen R&D chief Sean Harper hits the exits with a one-way ticket to early-stage biotech
7 years ago
First page
Previous page
85
86
87
88
89
90
91
Next page
Last page
Confirm Profile
Full Name
Email
Company
Job Title
{@!--CONSENT--!@}
Submit